|
gptkbp:instanceOf
|
federal agency
|
|
gptkbp:budget
|
$3.2 billion (2021)
|
|
gptkbp:collaboratesWith
|
local law enforcement
international agencies
|
|
gptkbp:currentHolder
|
gptkb:Anne_Milgram
|
|
gptkbp:drugInterdiction
|
international
domestic
|
|
gptkbp:employees
|
approximately 10,000
|
|
gptkbp:enforces
|
investigations
seizures
arrests
|
|
gptkbp:examiner
|
approximately 500
|
|
gptkbp:field
|
21
|
|
gptkbp:founded
|
1973
|
|
gptkbp:headCoach
|
Administrator
|
|
gptkbp:headquarters
|
gptkb:Arlington,_Virginia
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Drug Enforcement Agency
|
|
gptkbp:intelligence
|
approximately 1,000
|
|
gptkbp:jurisdiction
|
gptkb:United_States
|
|
gptkbp:mission
|
enforce the controlled substances laws
|
|
gptkbp:notableOperations
|
gptkb:Operation_Snowcap
gptkb:Operation_Pipeline
Operation Cassandra
Operation Con Air
Operation Blue Lightning
|
|
gptkbp:parent
|
gptkb:United_States_Department_of_Justice
|
|
gptkbp:partnerships
|
gptkb:Counterdrug_Technology_Assessment_Center
gptkb:National_Alliance_for_Drug_Endangered_Children
gptkb:National_Drug_Control_Strategy
gptkb:Drug-Free_Communities
Community Outreach
|
|
gptkbp:policy
|
opioids
controlled substances
methamphetamine
stimulants
cocaine
heroin
marijuana
narcotics
synthetic drugs
anabolic steroids
hallucinogens
|
|
gptkbp:publications
|
gptkb:DEA_Diversion_Control_Division
DEA_Drug_Threat_Assessment
DEA_Intelligence_Report
DEA_National_Drug_Threat_Assessment
|
|
gptkbp:specialties
|
approximately 5,000
|
|
gptkbp:training
|
gptkb:DEA_Training_Academy
drug trafficking
|
|
gptkbp:website
|
www.dea.gov
|